CVE-2020-1295
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint...
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint Elevation of Privilege Vulnerability'.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
8.8
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint Elevation of Privilege Vulnerability'.
- Record
CVE-2020-1295- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 6.5 Medium
AV:N/AC:L/Au:S/C:P/I:P/A:P - Updated
- 2026-11-02
CVE List No score
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint Elevation of Privilege Vulnerability'.
- Record
CVE-2020-1295- Updated
- 2026-11-02
EUVDEUVD-2020-12173 No score
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint Elevation of Privilege Vulnerability'.
- Record
EUVD-2020-12173- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-2fj7-pwvv-p427 No score
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint...
An elevation of privilege vulnerability exists in Microsoft SharePoint, aka 'Microsoft SharePoint Elevation of Privilege Vulnerability'.
- Record
GHSA-2fj7-pwvv-p427- Weakness
- CWE-269
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2020-1295 is a high vulnerability (CVSS 8.8) in Microsoft Sharepoint Enterprise Server, published June 9, 2020. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.96%, the 87th percentile. No source names a fixed version.